TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
TELA Bio (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has scheduled its fourth quarter and full year 2024 financial results announcement for Thursday, March 20, 2025.
The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring management's discussion of financial results and a corporate update. Interested investors must register in advance or at least 15 minutes before the call. Access to the live webcast and replay will be available through the Events & Presentations page in TELA's investor section website.
TELA Bio (NASDAQ: TELA), un'azienda tecnologica medica in fase commerciale specializzata in soluzioni per la ricostruzione dei tessuti molli, ha programmato l'annuncio dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 per giovedì 20 marzo 2025.
L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ET dello stesso giorno, durante la quale la direzione discuterà i risultati finanziari e fornirà un aggiornamento aziendale. Gli investitori interessati devono registrarsi in anticipo o almeno 15 minuti prima della chiamata. L'accesso al webcast dal vivo e alla registrazione sarà disponibile attraverso la pagina Eventi & Presentazioni nella sezione investitori del sito web di TELA.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica en etapa comercial especializada en soluciones de reconstrucción de tejidos blandos, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 20 de marzo de 2025.
La empresa realizará una conferencia telefónica y un webcast a las 4:30 p.m. ET el mismo día, donde la dirección discutirá los resultados financieros y ofrecerá una actualización corporativa. Los inversores interesados deben registrarse con anticipación o al menos 15 minutos antes de la llamada. El acceso al webcast en vivo y a la repetición estará disponible a través de la página de Eventos y Presentaciones en la sección de inversores del sitio web de TELA.
TELA Bio (NASDAQ: TELA)는 연조직 재건 솔루션을 전문으로 하는 상업 단계의 의료 기술 회사로, 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 20일 목요일로 예정했습니다.
회사는 같은 날 오후 4시 30분 ET에 경영진의 재무 결과 논의 및 기업 업데이트를 포함한 컨퍼런스 콜 및 웹캐스트를 개최할 예정입니다. 관심 있는 투자자는 사전에 등록해야 하며, 통화 시작 최소 15분 전까지 등록해야 합니다. 실시간 웹캐스트 및 재생에 대한 접근은 TELA의 투자자 섹션 웹사이트의 이벤트 및 프레젠테이션 페이지를 통해 제공됩니다.
TELA Bio (NASDAQ: TELA), une entreprise de technologie médicale en phase commerciale spécialisée dans les solutions de reconstruction des tissus mous, a prévu d'annoncer ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le jeudi 20 mars 2025.
L'entreprise organisera une conférence téléphonique et un webinaire le même jour à 16h30 ET, au cours duquel la direction discutera des résultats financiers et fournira une mise à jour de l'entreprise. Les investisseurs intéressés doivent s'inscrire à l'avance ou au moins 15 minutes avant l'appel. L'accès au webinaire en direct et à la rediffusion sera disponible via la page Événements & Présentations dans la section investisseurs du site Web de TELA.
TELA Bio (NASDAQ: TELA), ein kommerzielles Medizintechnikunternehmen, das sich auf Lösungen zur Rekonstruktion von Weichgewebe spezialisiert hat, hat die Bekanntgabe seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Donnerstag, den 20. März 2025 angesetzt.
Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, in dem das Management die Finanzergebnisse und ein Unternehmensupdate besprechen wird. Interessierte Investoren müssen sich im Voraus oder mindestens 15 Minuten vor dem Anruf registrieren. Der Zugang zum Live-Webcast und zur Aufzeichnung wird über die Seite Veranstaltungen & Präsentationen im Investorenbereich der Website von TELA verfügbar sein.
- None.
- None.
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2024 financial results on Thursday, March 20, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Fourth Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Louisa Smith
ir@telabio.com
FAQ
When will TELA Bio release its Q4 and full year 2024 earnings?
What time is TELA Bio's Q4 2024 earnings conference call?
How can investors access TELA Bio's Q4 2024 earnings call?
What will be discussed in TELA Bio's upcoming earnings call?
